ID: MRFR/HC/1213-CR | 117 Pages | Author: Kinjoll Dey | February 2021
Kidney Stone Market Size was valued at USD 2.20 billion in 2022. The Kidney Stone Market industry is projected to grow from USD 2.30 Billion in 2023 to USD 3.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% during the forecast period (2023 - 2032). Growing adoption of minimally invasive stone removal procedures, and advancements in ureteroscopy techniques are the key market drivers boosting the growth of the kidney stone market.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The rapid adoption of Minimally Invasive Surgical (MIS) techniques by surgeons has led to a wide variety of applications. In general surgery, minimally invasive methods are being adopted more often than open surgeries. The minimal side effects of MIS procedures compared to open surgery will increase the demand for advanced procedures to manage kidney stones. The journal Advances in Chronic Kidney Diseases states that minimally invasive treatments have been widely used for three of the most common stone diseases in America extracorporeal, ureteroscopic, and percutaneous renal lithotomy. Procedures that were previously open to the public are now being performed by minimally invasive surgeons.
The kidney stone market segmentation, based on type, includes calcium oxalate stones, uric acid, struvite kidney stones, cystine stones, and calcium phosphate stones. The calcium oxalate stones type segment held the majority share in 2022 with respect to the kidney stone market revenue. This is primarily owing to the high level of oxalate in the urine and lesser intake of water. Also, various risk factors including intake of a diet containing high levels of protein, oxalate, sodium, or sugar may result in calcium oxalate stones formation.
June 2022 Dornier MedTech and Endoluxe signed a multi-year exclusive distribution contract. Dornier and Endoluxe provide products and systems targeted toward the urology market, offering innovation and value
The kidney stone market segmentation, based on treatment type, includes medications, extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrolithotomy. The ureteroscopy segment dominated the market in 2022 with respect to the kidney stone market revenue. This is due to the offering to break up stones, take out suspicious-looking tissue, and have an unobstructed urinary tract view.
The kidney stone Market segmentation, based on diagnosis includes ultrasound, intravenous pyelography, CT scan, x-ray, and others. Ultrasound held the largest market share in 2022 with respect to the kidney stone market revenue. This is attributed to the no exposure to radiation, the growing popularity, and the showing of anatomical detail of the kidney in a very less time. It is a safe and painless test that uses sound waves to make images of the kidneys, ureters, and bladder.
September 2019 Dornier MedTech (Dornier), a urology firm and expert in kidney stone therapy, introduced the innovative OptiVision technology for the Dornier Delta III. It is the first imaging system that uses post-processing made exclusively to enhance stone therapy results. Urologists can visualize stones more clearly with OptiVision during extracorporeal shock wave lithotripsy (ESWL) procedures
Figure 2 Kidney Stone Market, by Diagnosis, 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America kidney stone held the largest market share in 2022. This is attributed to the developed healthcare infrastructure, favorable government policies, and presence of major key companies headquarters in the region are driving the market in the region. Additionally, it is projected that supportive government measures and an increase in research collaborations will accelerate industry development.
Further, the major countries studied are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 KIDNEY STONE MARKET SIZE BY REGION 2022 & 2030 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe kidney stone market accounts for the second-largest market share due to the increasing prevalence of kidney stone disease and the rise in the elderly population across Europe. However, the lack of awareness regarding renal stones hinders market growth. Further, the Germany kidney stone market held the largest market share, and the UK kidney stone market was the fastest-growing market in the European region.
The Asia-Pacific kidney stone market is expected to grow at a significant growth rate during the forecast period. This is due to the rising incidence of kidney stones, the rapidly building healthcare infrastructure, the growing government support, and the rising number of startups in this region. Moreover, China kidney stone market held the largest market share, and the India kidney stone market was the fastest-growing market in the Asia-Pacific region. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2023–2030.
Kidney Stone Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the kidney stone market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, including new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the kidney stone industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the kidney stone industry to benefit clients and expand the kidney stone market sector is to manufacture locally to reduce operating costs.
Boston Scientific Corporation (US) is a worldwide developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties. The company collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, and increase efficiencies. Its product portfolio is majorly divided into endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, and urology & pelvic health. In September 2021, Boston Scientific Corporation acquired a surgical business of Lumenis Ltd. (Israel) a privately held company that develops and commercializes energy-based medical solutions, from an affiliate of Baring Private Equity Asia (BPEA). The Lumenis surgical business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.
Key Companies in the Kidney Stone Market Includes
Kidney Stone Industry Developments
June 2022 Olympus, a technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the launch of the SoltiveTM SuperPulsed Laser System, a new thulium fiber laser application designed for stone lithotripsy and soft tissue applications
June 2020 Boston Scientific Corporation announced that it had entered into a binding deal with Synergy Innovation to acquire the majority investment in M.I Tech Co., Ltd, ( South Korea) a publicly traded Korean manufacturer and distributor of endoscopic and urologic medical devices
Report Attribute/Metric | Details |
Market Size 2022 | USD 2.20 billion |
Market Size 2023 | USD 2.30 billion |
Market Size 2032 | USD 3.9 billion |
Compound Annual Growth Rate (CAGR) | 4.3% (2023-2032) |
Base Year | 2022 |
Forecast Period | 2023-2032 |
Historical Data | 2019-2021 |
Forecast Units | Value (USD Billion) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Treatment Type, Diagnosis and Region |
Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Stryker Corporation (US), Convergent Laser Technologies (US), Boston Scientific Corporation (US), Cook Medical Inc. (US), DirexGroup (US), Siemens Healthcare GmbH (Germany), R. Bard Inc. (US), Dornier MedTech GmbH (Germany), Olympus Corporation (Japan), Richard Wolf GmbH (US) |
Key Market Opportunities | Rising awareness regarding overall kidney health |
Key Market Dynamics | Growing adoption of minimally invasive stone removal procedures Favorable reimbursement for lithotripsy procedures |
The Kidney Stone Market is anticipated to reach USD 3.9 billion at a CAGR of 4.3% during the forecast period of 2023 to 2032
The US Kidney Stone Market share is 35-40% during the forecast period of 2023 to 2032
The Kidney Stone Market is expected to register a CAGR of 4.3% during the forecast period of 2023 to 2032.
The North America held the largest market share in the Kidney Stone Market
Stryker Corporation (US), Convergent Laser Technologies (US), Boston Scientific Corporation (US), Cook Medical Inc. (US), DirexGroup (US), Siemens Healthcare GmbH (Germany)
The ureteroscopy treatment type led the Kidney Stone Market
The ultrasound diagnosis segment led the Kidney Stone Market
Key Questions Answered
Why Choose Market Research Future?